Corbus Pharmaceuticals
CRBP
CRBP
34 hedge funds and large institutions have $4.54M invested in Corbus Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.
Holders
34
Holders Change
+7
Holders Change %
+25.93%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
7
Closed
1
Calls
$214K
Puts
$1K
Net Calls
+$213K
Net Calls Change
-$22K
Top Buyers
| 1 |
1
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$134K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$7.19K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$230K |
| 4 |
4
Morgan Stanley
New York
|
$24.8K |
| 5 |
5
Citigroup
New York
|
$3.42K |
Top Sellers
| 1 |
1
Dimensional Fund Advisors
Austin,
Texas
|
$101K |
| 2 |
2
JPMorgan Chase & Co
New York
|
$3.28K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$1.94K |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$205 |
| 5 |
5
Group One Trading
Chicago,
Illinois
|
$10.9K |
